RHB Retail Research

Author: rhboskres   |   Latest post: Fri, 17 Jan 2020, 9:43 AM


Luxchem Corp - Expansions on Track; Stay BUY

Author:   |    Publish date:

  • Keep BUY and MYR0.59 TP with 27% expected total return. With Luxchem Corp currently trading at 10.6x P/E of FY20F EPS, vis-à-vis its 5-year +1SD of 11.6x and FBMSC’s current forward P/E of 16.8x, we believe the stock has the potential to rebound – sweetened by a 4% yield. Moving into FY20, margins for its trading segment are expected to normalise, hence anchoring our forecasts for a modest PATAMI growth of 3.8%.
  • Update on key business expansion initiatives. Recall that the company is building a new warehouse on a piece of reclaimed land at Pulau Indah with a capex of MYR17m allocated – entirely internally funded. On completion, the warehouse will have a floor space of 130,000sq ft. The project has reached 20% completion, with earthworks almost completed, while pilling has hit 50% completion. Upon completion, the new warehouse is expected to generate cost savings in terms of reduced rental payments. Luxchem manufacturing arm Transform Master’s (TMSB) plant expansion to 18,000tpa from 13,800tpa currently is on track for completion by year’s end. TMSB was acquired in 2016. During this period, its manufacturing capacity stood at 9,600tpa.
  • No change to forecasts while expecting PBT margins for the trading segment to improve in FY20. We forecast FY19 PATAMI growth at 2.5% on better PBT margins for its manufacturing segment (18%), which offset its trading segment’s weak margins (FY19: 4%). For 9M19, Luxchem’s trading segment realised a PBT margin of 3.9%, which is near the low end of its last 5-year range of between 3.5% and 5.2% due to keener competition. Moving into FY20, we are expecting this segment to record a better margin of 4.4%. This is premised on expectations that the domestic glove sector will continue to see an annual organic growth of between 5% and 8% and that the sector’s financial performance will improve in FY20 after a relatively uneven performance in FY19 – this should alleviate the pricing pressure for the suppliers, including Luxchem.
  • Maintain BUY with unchanged TP of MYR0.59 based on an unchanged 13x P/E on EPS of 4.5 sen. Despite the competitive nature of its business, we still like Luxchem for its relatively stable bottomline, strong operating cash flow, low capex intensity, net cash balance sheet, and healthy and sustainable ROE. This reflects management’s conservative style, where it has adopted measured expansion plans.

Source: RHB Securities Research - 9 Dec 2019

Share this

Related Stocks

Chart Stock Name Last Change Volume 
LUXCHEM 0.47 -0.005 (1.05%) 56,200 

  Patrick13 likes this.


308  374  520  783 

Top 10 Active Counters
 PWRWELL 0.29+0.005 
 MTOUCHE-WC 0.01-0.015 
 HSI-H8K 0.195+0.06 
 DGB 0.13-0.005 
 MTOUCHE 0.17-0.005 
 HSI-C7K 0.275-0.12 
 VC 0.075-0.01 
 SAPNRG 0.27+0.005 
 XDL-WD 0.015-0.005 
 XDL 0.16-0.005 


1. Leveraged & Inverse ETF CMS


1. Bank Negara MPC cuts OPR by 25bp to 2.75% save malaysia!!!
2. 【科技成长股】INARI AMERTRON BERHAD – One of EMS Industries Benefit from Cadence and Broadcom Collaboration. 【科技成长股】INARI AMERTRON BERHAD – Benefit from Cadence and Broadcom Collaboration. What Next?
3. China will keep buying our palm oil, Darell Leiking says save malaysia!!!
4. Dayang: Only fools will sell - Koon Yew Yin Koon Yew Yin's Blog
5. Notion Vtec Berhad – PART I - by Davidtslim: A high precision metal parts Specialist who rides on Electronic Manufacturing Services (“EMS”) Davidtslim sharing
6. 4大手套股发“灾难财” 星洲日報/投資致富‧企業故事
7. Top Glove and Supermax: Potential Beneficiaries Amid Coronavirus Outbreak KL Trader Investment Research Articles
8. 不是叫你买股 - NOTION篇,火后凤凰? 作者 JC JC
Partners & Brokers